|
Balance Sheet Cash Flow Statement 3155 Porter Dr. Palo Alto, CA 94304-1213 CA Tel. 650-475-3100 Fax 650-475-3101 |
Type: Public
On the web:
http://www.stemcellsinc.com
Employees:
55
Employee growth: (12.7%)
StemCells hopes a small focus will mean big business. The company discovers cell-based therapies to treat diseases of the central nervous system (CNS), such as cerebral palsy and Alzheimer's disease, as well as spinal cord injury. It is researching stem cell and progenitor cell (cells that have developed from stem cells) therapies to repair neural tissue damaged by disease and injury, and has discovered markers for CNS stem cells and a way to reproduce them for transplant. Its lead therapy candidate may treat Batten disease, a fatal genetic enzyme deficiency. In addition to its CNS research, StemCells is also studying liver cells, hoping to find treatments for diseases such as hepatitis and liver cancer.
Key numbers for fiscal year ending December, 2008:
Sales: $0.2M
One year growth: 308.5%
Net income: ($29.1)M
Officers:
Chairman: John J. Schwartz
President, CEO, and Director; President, StemCells California: Martin M. McGlynn
SVP Development and Operations: Stewart Craig
Competitors:
Advanced Cell Technology
Geron
ReNeuron
